Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple myeloma
Pharma
J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win
J&J says it plans to present the Tecvayli combo data to health authorities and disclose the detailed myeloma results at an upcoming medical meeting.
Fraiser Kansteiner
Oct 16, 2025 8:10am
J&J, Legend debut first TV ad for multiple myeloma med Carvykti
Jul 30, 2025 2:56pm
FDA delays decision on GSK's Blenrep comeback by 3 months
Jul 23, 2025 2:50pm
FDA advisors vote against GSK's Blenrep comeback
Jul 17, 2025 3:14pm
Fierce Biotech
AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer
Jul 10, 2025 9:01am
Regeneron snags FDA nod for myeloma bispecific Lynozyfic
Jul 2, 2025 11:29am
